Report Detail
Global Sotalol Market Insights, Forecast to 2025
- RnM3358007 |
- 27 April, 2019 |
- Global |
- 114 Pages |
- QYResearch |
- Pharma & Healthcare
Sotalol is a medication used to treat abnormal heart rhythms. Sotalol is a non-selective competitive beta-adrenergic receptor blocker that also exhibits Class III antiarrhythmic properties.
The global Sotalol market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Sotalol market based on company, product type, end user and key regions.
This report studies the global market size of Sotalol in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Sotalol in these regions.
This research report categorizes the global Sotalol market by top players/brands, region, type and end user. This report also studies the global Sotalol market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Bayer
GSK
Bristol-Myers Squibb (BMS)
Arbor Pharmaceuticals
Cambrex
Arevipharma
Shaanxi Hanjiang Pharmaceutical Group
Samarth Pharma Pvt. Ltd.
Cipla Limited
Market size by Product
40mg
80mg
Market size by End User
Sustained Ventricular Tachycardia
Atrial Fibrillation/Flutter
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Sotalol market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Sotalol market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Sotalol companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Sotalol submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Sotalol are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (M Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Sotalol market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Sotalol Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Sotalol Market Size Growth Rate by Product
- 1.4.2 40mg
- 1.4.3 80mg
- 1.5 Market by End User
- 1.5.1 Global Sotalol Market Size Growth Rate by End User
- 1.5.2 Sustained Ventricular Tachycardia
- 1.5.3 Atrial Fibrillation/Flutter
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Sotalol Market Size
- 2.1.1 Global Sotalol Revenue 2014-2025
- 2.1.2 Global Sotalol Sales 2014-2025
- 2.2 Sotalol Growth Rate by Regions
- 2.2.1 Global Sotalol Sales by Regions
- 2.2.2 Global Sotalol Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Sotalol Sales by Manufacturers
- 3.1.1 Sotalol Sales by Manufacturers
- 3.1.2 Sotalol Sales Market Share by Manufacturers
- 3.1.3 Global Sotalol Market Concentration Ratio (CR5 and HHI)
- 3.2 Sotalol Revenue by Manufacturers
- 3.2.1 Sotalol Revenue by Manufacturers (2014-2019)
- 3.2.2 Sotalol Revenue Share by Manufacturers (2014-2019)
- 3.3 Sotalol Price by Manufacturers
- 3.4 Sotalol Manufacturing Base Distribution, Product Types
- 3.4.1 Sotalol Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Sotalol Product Type
- 3.4.3 Date of International Manufacturers Enter into Sotalol Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Sotalol Sales by Product
- 4.2 Global Sotalol Revenue by Product
- 4.3 Sotalol Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Sotalol Breakdown Data by End User
6 North America
- 6.1 North America Sotalol by Countries
- 6.1.1 North America Sotalol Sales by Countries
- 6.1.2 North America Sotalol Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Sotalol by Product
- 6.3 North America Sotalol by End User
7 Europe
- 7.1 Europe Sotalol by Countries
- 7.1.1 Europe Sotalol Sales by Countries
- 7.1.2 Europe Sotalol Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Sotalol by Product
- 7.3 Europe Sotalol by End User
8 Asia Pacific
- 8.1 Asia Pacific Sotalol by Countries
- 8.1.1 Asia Pacific Sotalol Sales by Countries
- 8.1.2 Asia Pacific Sotalol Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Sotalol by Product
- 8.3 Asia Pacific Sotalol by End User
9 Central & South America
- 9.1 Central & South America Sotalol by Countries
- 9.1.1 Central & South America Sotalol Sales by Countries
- 9.1.2 Central & South America Sotalol Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Sotalol by Product
- 9.3 Central & South America Sotalol by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Sotalol by Countries
- 10.1.1 Middle East and Africa Sotalol Sales by Countries
- 10.1.2 Middle East and Africa Sotalol Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Sotalol by Product
- 10.3 Middle East and Africa Sotalol by End User
11 Company Profiles
- 11.1 Bayer
- 11.1.1 Bayer Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Bayer Sotalol Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Bayer Sotalol Products Offered
- 11.1.5 Bayer Recent Development
- 11.2 GSK
- 11.2.1 GSK Company Details
- 11.2.2 Company Business Overview
- 11.2.3 GSK Sotalol Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 GSK Sotalol Products Offered
- 11.2.5 GSK Recent Development
- 11.3 Bristol-Myers Squibb (BMS)
- 11.3.1 Bristol-Myers Squibb (BMS) Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Bristol-Myers Squibb (BMS) Sotalol Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Bristol-Myers Squibb (BMS) Sotalol Products Offered
- 11.3.5 Bristol-Myers Squibb (BMS) Recent Development
- 11.4 Arbor Pharmaceuticals
- 11.4.1 Arbor Pharmaceuticals Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Arbor Pharmaceuticals Sotalol Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Arbor Pharmaceuticals Sotalol Products Offered
- 11.4.5 Arbor Pharmaceuticals Recent Development
- 11.5 Cambrex
- 11.5.1 Cambrex Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Cambrex Sotalol Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Cambrex Sotalol Products Offered
- 11.5.5 Cambrex Recent Development
- 11.6 Arevipharma
- 11.6.1 Arevipharma Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Arevipharma Sotalol Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Arevipharma Sotalol Products Offered
- 11.6.5 Arevipharma Recent Development
- 11.7 Shaanxi Hanjiang Pharmaceutical Group
- 11.7.1 Shaanxi Hanjiang Pharmaceutical Group Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Shaanxi Hanjiang Pharmaceutical Group Sotalol Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Shaanxi Hanjiang Pharmaceutical Group Sotalol Products Offered
- 11.7.5 Shaanxi Hanjiang Pharmaceutical Group Recent Development
- 11.8 Samarth Pharma Pvt. Ltd.
- 11.8.1 Samarth Pharma Pvt. Ltd. Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Samarth Pharma Pvt. Ltd. Sotalol Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Samarth Pharma Pvt. Ltd. Sotalol Products Offered
- 11.8.5 Samarth Pharma Pvt. Ltd. Recent Development
- 11.9 Cipla Limited
- 11.9.1 Cipla Limited Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Cipla Limited Sotalol Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Cipla Limited Sotalol Products Offered
- 11.9.5 Cipla Limited Recent Development
12 Future Forecast
- 12.1 Sotalol Market Forecast by Regions
- 12.1.1 Global Sotalol Sales Forecast by Regions 2019-2025
- 12.1.2 Global Sotalol Revenue Forecast by Regions 2019-2025
- 12.2 Sotalol Market Forecast by Product
- 12.2.1 Global Sotalol Sales Forecast by Product 2019-2025
- 12.2.2 Global Sotalol Revenue Forecast by Product 2019-2025
- 12.3 Sotalol Market Forecast by End User
- 12.4 North America Sotalol Forecast
- 12.5 Europe Sotalol Forecast
- 12.6 Asia Pacific Sotalol Forecast
- 12.7 Central & South America Sotalol Forecast
- 12.8 Middle East and Africa Sotalol Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Sotalol Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Sotalol. Industry analysis & Market Report on Sotalol is a syndicated market report, published as Global Sotalol Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Sotalol market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
